We are live on ! Find out more
MA

Montag & Associates Portfolio holdings

AUM $2.15B
1-Year Est. Return 20.86%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+20.86%
3 Year Est. Return
+68%
5 Year Est. Return
+82.09%
10 Year Est. Return
+321.81%
AUM
$613M
AUM Growth
+$21.7M
Cap. Flow
-$3.21M
Cap. Flow %
-0.52%
Top 10 Hldgs %
22.48%
Holding
251
New
18
Increased
52
Reduced
87
Closed
9

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$4.1M
2
LLY icon
Eli Lilly
LLY
+$3.04M
3
INGR icon
Ingredion
INGR
+$2.73M
4
CSCO icon
Cisco
CSCO
+$2.62M
5
TDW icon
Tidewater
TDW
+$2.35M

Top Sells

Rank Stock Value
1
CF icon
CF Industries
CF
+$4.8M
2
HII icon
Huntington Ingalls Industries
HII
+$3.97M
3
WY icon
Weyerhaeuser
WY
+$3.94M
4
OMC icon
Omnicom Group
OMC
+$3.72M
5
CTRA
Coterra Energy
CTRA
+$2.64M

Sector Composition

Rank Sector Weight
1 Healthcare 12.05%
2 Financials 10.79%
3 Industrials 9.01%
4 Consumer Staples 8.86%
5 Technology 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CUZ icon
176
Cousins Properties
CUZ
$5.22B
$499K 0.08%
14,195
+188
+1% +$6.3K
MDT icon
177
Medtronic
MDT
$111B
$495K 0.08%
7,758
– –
T icon
178
AT&T
T
$169B
$491K 0.08%
18,385
-690
-4% -$18.5K
LHX icon
179
L3Harris
LHX
$56.9B
$485K 0.08%
6,400
– –
SO icon
180
Southern Company
SO
$109B
$484K 0.08%
10,666
+893
+9% +$39.5K
FNF icon
181
Fidelity National Financial
FNF
$14.6B
$483K 0.08%
25,847
-37,585
-59% -$703K
CFN
182
DELISTED
CAREFUSION CORPORATION
CFN
$459K 0.07%
10,350
– –
Y
183
DELISTED
Alleghany Corp
Y
$456K 0.07%
1,040
– –
EXC icon
184
Exelon
EXC
$48.4B
$452K 0.07%
17,364
-88,634
-84% -$2.26M
ENOV icon
185
Enovis
ENOV
$1.7B
$431K 0.07%
3,362
+12
+0.4% +$1.5K
NBR icon
186
Nabors Industries
NBR
$1.12B
$427K 0.07%
291
– –
EGN
187
DELISTED
Energen
EGN
$427K 0.07%
4,800
+64
+1% +$5.38K
NXPI icon
188
NXP Semiconductors
NXPI
$65.4B
$414K 0.07%
+6,250
New +$383K
ETP
189
DELISTED
Energy Transfer Partners, L.P.
ETP
$410K 0.07%
8,700
– –
PCAR icon
190
PACCAR
PCAR
$72.7B
$408K 0.07%
9,750
– –
MPC icon
191
Marathon Petroleum
MPC
$89.3B
$390K 0.06%
10,000
– –
MO icon
192
Altria Group
MO
$125B
$386K 0.06%
9,202
-76
-0.8% -$3.06K
FIS icon
193
Fidelity National Information Services
FIS
$23.2B
$383K 0.06%
7,000
– –
PSX icon
194
Phillips 66
PSX
$82.5B
$378K 0.06%
4,696
-235
-5% -$19.4K
ADP icon
195
Automatic Data Processing
ADP
$106B
$365K 0.06%
5,239
– –
IYH icon
196
iShares US Healthcare ETF
IYH
$3.46B
$365K 0.06%
14,250
– –
HUM icon
197
Humana
HUM
$46.7B
$343K 0.06%
2,684
– –
MRO
198
DELISTED
Marathon Oil Corporation
MRO
$339K 0.06%
8,500
– –
MMP
199
DELISTED
Magellan Midstream Partners, L.P.
MMP
$336K 0.05%
4,000
– –
HVT.A icon
200
Haverty Furniture Companies Class A
HVT.A
$330K 0.05%
13,199
-1,000
-7% -$25.5K
6 7
8
9 10

Similar funds

IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.16B AUM 18.08% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return

Montag & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Montag & Associates held 251 positions worth $613M, up 3.7% from $592M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Montag & Associates's Q2 2014 filing shows 18 new, 52 increased, 87 reduced and 9 closed positions. Its largest new stake was Gilead Sciences: 52,627 shares worth $4.36M. The largest sale was CF Industries, an estimated $4.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Montag & Associates's largest Q2 2014 buy was Gilead Sciences: 52,627 shares worth $4.36M.
  • Montag & Associates added most to Eli Lilly in Q2 2014, an estimated $3.04M increase.
  • Montag & Associates's biggest Q2 2014 reduction was Huntington Ingalls Industries, cutting an estimated $3.97M.
  • Montag & Associates fully exited CF Industries in Q2 2014, selling an estimated $4.8M.
  • Montag & Associates's ten largest holdings make up 22% of its $613M portfolio in Q2 2014.
  • Montag & Associates opened 18 new positions and closed 9 in Q2 2014.
  • Montag & Associates's portfolio value rose 3.7% quarter-over-quarter to $613M.

Based on Montag & Associates's 13F filing for Q2 2014, filed 6 Aug 2014.